Literature DB >> 27056211

Draft Genome Sequence of a Vancomycin-Resistant and Vancomycin-Dependent Enterococcus faecium Isolate.

Marion Blaschitz1, Sarah Lepuschitz1, Laura Wagner1, Franz Allerberger1, Alexander Indra1, Werner Ruppitsch2, Steliana Huhulescu1.   

Abstract

Vancomycin-resistant enterococci have emerged as major nosocomial pathogens worldwide. While antimicrobial pressure promotes nosocomial colonization with these enterococci, prolonged exposure to vancomycin may foster the transition from vancomycin resistance to vancomycin dependence. Here, we report the draft genome sequence of a vancomycin-dependentEnterococcus faeciumisolate showing partial teicoplanin dependence.
Copyright © 2016 Blaschitz et al.

Entities:  

Year:  2016        PMID: 27056211      PMCID: PMC4824244          DOI: 10.1128/genomeA.00059-16

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Vancomycin-resistant enterococci (VRE) are major nosocomial pathogens worldwide. While antimicrobial pressure promotes nosocomial colonization with VRE, prolonged exposure to vancomycin may foster the transition from vancomycin resistance to dependence (1). Enterococci showing growth on medium containing 6 µg/ml vancomycin and an MIC of >8 µg/ml are considered vancomycin resistant. Strains unable to grow in the absence of 6 µg/ml vancomycin, despite multiple subcultures, are considered vancomycin dependent (1). Vancomycin-dependent enterococcus (VDE) was first described in 1993 (2, 3). To our knowledge, only twenty-five cases of VDE have been described worldwide so far (4). We report here the draft genome of a VRE/VDE isolate obtained in Austria in 2007 from an oncology patient 1 month after cessation of teicoplanin therapy (5). The described strain of VDE showed resistance to penicillin (MIC, 64 µg/ml), ampicillin (MIC, 128 µg/ml), amoxicillin-clavulanate (amoxicillin MIC, >256 µg/ml), erythromycin (MIC, 8 µg/ml), clindamycin (MIC, 8 µg/ml), ciprofloxacin (MIC, >2 µg/ml), moxifloxacin (MIC, >2 µg/ml), fusidic acid (MIC, 4 µg/ml), and low-level resistance to gentamicin (MIC, 32 µg/ml) when tested according to Clinical and Laboratory Standards Institute (CLSI) standards (6). The strain was susceptible to quinupristin-dalfopristin (MIC, <0.5 µg/ml), oxytetracycline (MIC, <0.5 µg/ml), linezolid (MIC, 2 µg/ml), chloramphenicol (MIC, 8 µg/ml), and mupirocin (MIC, 2 µg/ml). The strain showed intermediate resistance to teicoplanin when tested on Mueller-Hinton agar (bioMérieux, Marcy l’Etoile, France) using a 30-µg teicoplanin disc (Oxoid, Basingstoke, United Kingdom) or a teicoplanin Epsilon test strip (AB Biodisk, Solna, Sweden) (MIC, 8 µg/ml). It also showed partial teicoplanin dependence, i.e., it grew in the area of low concentration of teicoplanin (0.016 to 6 µg/ml) but was inhibited in the area with high teicoplanin concentrations (8 to 256 µg/ml). The strain showed high-level resistance to vancomycin (MIC, >256 µg/ml) and complete vancomycin dependence when tested on Mueller-Hinton agar (bioMérieux) with a 30-µg vancomycin disk (Oxoid) or a vancomycin Epsilon test strip (AB Biodisk). The strain also showed in vitro reversion to vancomycin-nondependent vancomycin-resistant Enterococcus faecium mutants. The MagAttract high-molecular-weight (HMW) DNA kit (Qiagen, Hilden, Germany) was used to isolate genomic DNA from overnight cultures grown on Mueller-Hinton agar plates (bioMérieux) with a 30-µg vancomycin disk (Oxoid) and a 30-µg teicoplanin disk (Oxoid). The fragment library was prepared using the Nextera XT kit (Illumina, Inc., San Diego, CA) and 1 ng of genomic DNA. Paired-end sequencing (2 × 300 bp) was performed on a MiSeq (Illumina, Inc.), generating 1,365,744 reads from 333,173,006 unassembled nucleotides. Raw reads were de novo assembled into a draft genome using Velvet version 1.1.04 (7). Contigs were filtered for a minimum coverage of 5 and minimum length of 200 bp, which resulted in 232 contigs with a total of 2,949,766 nucleotides at a coverage of 95-fold. A total of 2,953 genes, 2,878 coding sequences, 95 pseudogenes, 7 rRNA genes, and 64 tRNA genes were identified using the NCBI Prokaryotic Genome Annotation Pipeline (http://www.ncbi.nlm.nih.gov/genome/annotation_prok/).

Nucleotide sequence accession numbers.

This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession no. LQRS00000000. The version described in this paper is the first version, LQRS01000000.
  6 in total

1.  Velvet: algorithms for de novo short read assembly using de Bruijn graphs.

Authors:  Daniel R Zerbino; Ewan Birney
Journal:  Genome Res       Date:  2008-03-18       Impact factor: 9.043

2.  Partial teicoplanin dependence in a vancomycin-dependent Enterococcus faecium isolated from an oncology patient 1 month after cessation of teicoplanin therapy, Austria 2007.

Authors:  Steliana Huhulescu; Daniela Schmid; Barbara Mayer; Silke Stadlbauer; Günther Wewalka; Franz Allerberger; Michael Dworzak
Journal:  Int J Antimicrob Agents       Date:  2007-11-14       Impact factor: 5.283

3.  Isolation and characterization of the first vancomycin-dependent Enterococcus from India.

Authors:  T Banerjee; S Anupurba
Journal:  Indian J Med Microbiol       Date:  2013 Jan-Mar       Impact factor: 0.985

4.  Bacteremia due to vancomycin-dependent Enterococcus faecium.

Authors:  M Green; J H Shlaes; K Barbadora; D M Shlaes
Journal:  Clin Infect Dis       Date:  1995-03       Impact factor: 9.079

5.  Urinary tract infection with an Enterococcus faecalis isolate that requires vancomycin for growth.

Authors:  H S Fraimow; D L Jungkind; D W Lander; D R Delso; J L Dean
Journal:  Ann Intern Med       Date:  1994-07-01       Impact factor: 25.391

6.  Nosocomial infection with vancomycin-dependent enterococci.

Authors:  Paul A Tambyah; John A Marx; Dennis G Maki
Journal:  Emerg Infect Dis       Date:  2004-07       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.